Algotec adds value for Gerald Schwartz’s Onex

The medical IT field is hot as President Obama’s health-care act requires clinics to computerize.

By GALI WEINREB / GLOBES
August 27, 2011 23:22
A patient looks at his X-ray

311_medical x-ray. (photo credit: Courtesy)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

In 2003, medical-imaging-systems developer Algotec Systems was acquired by Eastman Kodak Inc. for $42.5 million. It was one of the two medicalimaging companies Kodak acquired in Israel, the other being Orex Computed Radiography for $63m. At the time, Kodak also acquired digital-printing developers in what seemed to be the beginning of a beautiful friendship between the US giant and Israeli hi-tech.

However, just four years later, Kodak decided to quit the medical- imaging business, and Agotec and Orex were sold together with the rest of the business to Canada’s Onex Corporation, controlled by chairman and CEO Gerald Schwartz. Onex was an unknown entity in Israel at the time, which portended poorly for the Israeli firms’ future.

Be the first to know - Join our Facebook page.


Today it appears that the sale only benefited the Israeli firms.

Kodak’s health-care unit became Carestream Health Inc., and its owner, Schwartz, a Jewish Canadian, subsequently became a well-known figure in Israel. At one point he even considered buying the Maccabi Tel Aviv soccer club. He is a generous donor to the IDF, has bought a building on Tel Aviv’s Rothschild Boulevard and is an associate of Prime Minister Binyamin Netanyahu.

Schwartz is ranked 1,140th in the Forbes billionaires list. He is considered one of the world’s prominent pro-Israel billionaires.

Meanwhile, Algotec Systems has done very well as a unit of Carestream. Algotec currently has 150 employees, and it is Carestream’s main IT development center. Dr. Elad Benjamin, the son of Algotec founder Dr.

Menashe Benjamin, and who was the company’s vice president for marketing at the time of the sale, now not only runs Algotec from his Israeli office, but also Carestream’s entire IT division.



Carestream’s IT division has 650 employees and an annual turnover of $200m. Its customers include insurance giants such as US HMO Kaiser Permanente and Israel’s Clalit Health Services, one of the world’s largest health insurers. Carestream operates worldwide, including at 25 hospitals in Saudi Arabia.

Thanks to Obama’s incentives

Onex, which has a market cap of C$3.8 billion, has started to consider floating Carestream.

Since then, the expectations from Benjamin’s IT solutions division have grown.

“We have an opportunity to grow and add value to Carestream out of proportion to our size within the company, thanks to information technology trends,” Benjamin told Globes in an interview. “While the film sector, where some other Carestream units are engaged, is frozen and even waning, medical digital imaging is on fire.”

One of the reasons for the trend is US President Barack Obama’s health-care incentives program, which includes $2b.

just for computerization.

“Today only 20 percent of health clinics are computerized,” Benjamin said. “In the coming year every clinic that switches to a computer system will receive millions of dollars in incentives, and beginning in 2012 any clinic that isn’t computerized will be fined. The race by for clinics to computerize is driving the business of companies like ours.”

However, to reap the rewards, medical-computerization companies have to deal with some major challenges.

“In the past, a company that was engaged in digital imaging faced one challenge: to present the image,” Benjamin said.

“Today it’s clear that the main challenge is to make that image usable by doctors.”

“A hospital generates vast amounts of data that have to be presented quickly to a small number of decision makers,” he said. “The key is to give the doctor better tools that improve his ability to make decisions without feeling that he is overworked.”

Algotec gained this insight the hard way. It once developed a system for doctors that presented a 3-D image but discovered that the doctors didn’t use it because the image needed three to four seconds to upload, and the doctor had to view dozens of more images.

“Much of our know-how and patents are for presenting a 300- megabyte image very quickly,” Benjamin said.

Apart from speed, companies in the field have to cope with another challenge: integration.

“A large US hospital has 80 to 100 different information systems,” he said, “and we have to make it possible to pull different images from different systems and present them one on top of another. All this has to be possible with a few clicks.”

Globes: What about the data being held by the patient, such as on the current DiskOnKey or in a chip in the body in the future?

Benjamin: “The typical patient is a disorganized adult for whom the use of technology is no easy matter. I don’t think the patient will manage the data himself.

Google thinks the same and gave up its venture in this field.

“However, the patient definitely wants to be more involved in the management of his or her illness. In the coming years, one of the biggest challenges will be to figure out how to do this.”

In the coming years Algotec wants to expand into cardiology, ophthalmology and gynecological imaging.

What are the chances of an acquisition in Israel in these new fields?

“I wish there was something to buy. There is no significant medical computerization activity in Israel.”

There are experts who will swear that this is a thriving field in Israel. What about dbMotion Ltd. and eWave Ltd.?

“I prefer not to respond directly about specific companies, but I’m not excited by what I’ve seen here. Israelis are excellent at health applications for the enduser and in niche computing fields.”

How important is Gerry Schwartz’s involvement in Israel for the continuation of the Israeli development center?

“Gerry is not directly involved in the Israeli operations. He visits a few times a year. When we won a Clalit project he came and congratulated us on the win.

“Fortunately, the R&D center justifies itself, and there is no need to think twice whether it will stay in Israel or not. Gerry Schwartz supports the Israeli activity, and he and Onex have taken fire for it in Canada. But most of the fire is because of his political activity and donations, not because of our operations.”

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS